#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation

Jan 31, 2023

Click to read this study in The Lancet Oncology.

Author

admin

View all posts

ABOUT THE EXPERTS

Teddy Guo

Advertisement

[adinserter block="22" template="Multi-Media " check="exceptions" ignore="page-type"]

RECENT ARTICLES

Dual IO in Melanoma with BRAF Gene Mutations

Dual IO in Melanoma with BRAF Gene Mutations

An Arm and a Leg: New Lessons in the Fight for Charity Care

How Potential Medicaid Cuts Could Play Out in California

KFF Health News' 'What the Health?': A Colorful Cast Could Lead Key Health Agencies

#VisualAbstract Use of Certain Biologics or Disease Modifying Antirheumatic Drugs May Be Associated With Cancer Risk

#VisualAbstract Use of Certain Biologics or Disease Modifying Antirheumatic Drugs May Be Associated With Cancer Risk

Cadonilimab plus chemotherapy improves survival in recurrent or metastatic cervical cancer

Cadonilimab plus chemotherapy improves survival in recurrent or metastatic cervical cancer

PODCAST

How to Address & Process Emotional Trauma as a Physician

Dec 04, 2024

Improving Easy Access to Evidence-Based Medical Information, Part 2

Nov 27, 2024

Improving Easy Access to Evidence-Based Medical Information, Part 1

Nov 20, 2024

Business of Medicine

Medical Truths Behind Brain Rot

Medical Truths Behind Brain Rot

Identity Theft Issues in the Medical Office

Identity Theft Issues in the Medical Office

Why Successful Interoperability is Essential for Healthy Revenue

Why Successful Interoperability is Essential for Healthy Revenue

Defining the Standard of Care in Medical Malpractice

Defining the Standard of Care in Medical Malpractice

Advertisement

[adinserter block="6" template="Multi-Media " check="exceptions" ignore="page-type"]